Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: A pilot study from the Wisconsin Oncology Network
B. S. Kahl, W. L. Longo, J. C. Eickhoff, J. Zehnder, C. Jones, J. Blank, T. McFarland, W. Bottner, H. Rezazedeh, J. Werndli, H. H. Bailey
Dive into the research topics of 'Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: A pilot study from the Wisconsin Oncology Network'. Together they form a unique fingerprint.